WHO’s nuclear war assessment needs an update to reflect current threats

How should the next WHO director general confront the new world order?

Ambiguous guideline recommendations harm patient care

Why I can no longer be silent in the face of antisemitism in the NHS

One pill post stroke . . . and other research

Rammya Mathew: Recognising neurodiversity is important—but at what cost?

Proactive drug safety surveillance should be at the heart of the new Health Data Research Service

David Oliver: Overcrowded emergency departments are bad news for patients with delirium and dementia

Matt Morgan: It’s bland, inoffensive, and makes no difference—why tofu leadership should be off the NHS menu

Helen Salisbury: How to make patients feel safe